Throughout March, UK is spotlighting Women Making History. These women are leading their fields of research and impacting the lives of Kentuckians. For Allison Gibson, Ph.D., her passion is helping some of the most vulnerable Kentuckians.
The University of Kentucky is a site for the groundbreaking AHEAD study, the first-ever clinical trial to test the effect of a promising drug known as lecanemab.
The Pat Summitt Foundation presented a $25,000 grant to the University of Kentucky's Sanders-Brown Center on Aging (SBCoA) during the UK women’s basketball game against Auburn University on January 26, 2023.
Sanders-Brown Center on Aging is now a site for the first-ever clinical trial testing the effect lecanemab has in people with no cognitive symptoms of Alzheimer’s disease but have amyloid present in their brains.
Donna Wilcock, Ph.D., was awarded a $1.7 million National Institutes of Health grant for her lab’s exploration of adverse effects of two new Alzheimer’s disease drugs shown to slow the progression of cognitive decline.
The focus of the work done by Elizabeth Rhodus, Ph.D., is to enhance sensory input in order to improve behavioral symptoms in people with Alzheimer's disease and related dementias.
The Alzheimer’s Association welcomes the University of Kentucky’s Donna M. Wilcock, Ph.D., as the new editor-in-chief of Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
Linda J. Van Eldik, Ph.D., director of the University of Kentucky Sanders-Brown Center on Aging, is part of a $1.5 million grant to help further research into a possible treatment for Alzheimer’s disease.
David Fardo, Stephen W. Wyatt Endowed Professor in the College of Public Health, is one of 14 University Research Professors for 2022-23. He conducts research on dementia-related neuropathologies.
